Net loss of Genpharmasec reported to Rs 0.13 crore in the quarter ended March 2024 as against net profit of Rs 1.05 crore during the previous quarter ended March 2023. Sales rose 63.99% to Rs 10.20 crore in the quarter ended March 2024 as against Rs 6.22 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 0.13 crore in the year ended March 2024 as against net profit of Rs 1.12 crore during the previous year ended March 2023. Sales rose 19.16% to Rs 30.41 crore in the year ended March 2024 as against Rs 25.52 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales10.206.22 64 30.4125.52 19 OPM %-0.103.22 -0.131.02 - PBDT0.140.21 -33 0.290.30 -3 PBT0.110.20 -45 0.250.28 -11 NP-0.131.05 PL -0.131.12 PL Powered by Capital Market - Live News

Net loss of Genpharmasec reported to Rs 0.05 crore in the quarter ended March 2024 as against net profit of Rs 1.05 crore during the previous quarter ended March 2023. Sales rose 63.99% to Rs 10.20 crore in the quarter ended March 2024 as against Rs 6.22 crore during the previous quarter ended March 2023.For the full year,net profit declined 95.54% to Rs 0.05 crore in the year ended March 2024 as against Rs 1.12 crore during the previous year ended March 2023. Sales rose 19.16% to Rs 30.41 crore in the year ended March 2024 as against Rs 25.52 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales10.206.22 64 30.4125.52 19 OPM %1.573.54 -0.531.02 - PBDT0.330.22 50 0.490.30 63 PBT0.330.21 57 0.470.28 68 NP-0.051.05 PL 0.051.12 -96 Powered by Capital Market - Live News

Genpharmasec will hold a meeting of the Board of Directors of the Company on 24 May 2024Powered by Capital Market - Live News

Genpharmasec will hold a meeting of the Board of Directors of the Company on 27 March 2024.Powered by Capital Market - Live News

Genpharmasec will hold a meeting of the Board of Directors of the Company on 26 March 2024. The meeting would commence at 1.00 PM.Powered by Capital Market - Live News